Patents by Inventor Anu Desai

Anu Desai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for promoting bone and joint health
    Patent number: 8815306
    Abstract: Methods and compositions that can be used to promote bone and joint health through amelioration, stabilization and repair of damage associated with various pathophysiological conditions are disclosed.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: August 26, 2014
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Anu Desai, Amy J. Hall, Jeffrey S. Bland
  • PHYTONUTRIENT COMPOSITIONS AND METHODS OF USE
    Publication number: 20130337092
    Abstract: Phytonutrient based compositions and methods of using the same for preventing, reducing, or treating genetic damage induced by environmental toxins are disclosed. Additionally, said compositions and methods are used to reduce oxidized low density lipoproteins (OxLDL), myeloperoxidase (MPO), and plasminogen activator inhibitor-1 (PAI-1).
    Type: Application
    Filed: May 17, 2013
    Publication date: December 19, 2013
    Applicant: METAPROTEOMICS, LLC
    Inventors: Veera KONDA, Andrea Lyra HELLER, Anu DESAI, Brian CARROLL, Matthew L. TRIPP, Jeffrey S. BLAND
  • Methods and compositions for heavy metal detoxification
    Patent number: 8475850
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: July 2, 2013
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy J. Hall, Anu Desai, Jeffrey S. Bland
  • Protein kinase modulation by hops and products
    Patent number: 8263139
    Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: September 11, 2012
    Assignee: Metaproteonics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Linda M. Pacioretty, Jeffrey S. Bland, Amy J. Hall, Veera Konda, Anu Desai
  • Methods and compositions for heavy metal detoxification
    Patent number: 8241674
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: August 14, 2012
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy Hall, Anu Desai, Jeffrey S. Bland
  • METHODS AND COMPOSITIONS FOR HEAVY METAL DETOXIFICATION
    Publication number: 20120189721
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Application
    Filed: January 18, 2012
    Publication date: July 26, 2012
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy Hall, Anu Desai, Jeffrey S. Bland
  • Treatment modalities for autoimmune diseases
    Patent number: 7901714
    Abstract: Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: March 8, 2011
    Assignee: Metaproteomics, LLP
    Inventors: Matthew L. Tripp, Jeffrey S. Bland, Robert Lerman, Amy J. Hall, Veera Konda, Anu Desai
  • XANTHOHUMOL AND TETRAHYDRO-ISOALPHA ACID BASED PROTEIN KINASE MODULATION CANCER TREATMENT
    Publication number: 20110021637
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.
    Type: Application
    Filed: April 6, 2010
    Publication date: January 27, 2011
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Veera Konda, Amy Hall, Linda M. Pacioretty, Anu Desai
  • SUBSTITUTED 1, 3-CYCLOPENTADIONE ATTENUATED ENDOTHELIAL INFLAMMATION AND ENDOTHELIAL-MONOCYTE INTERACTIONS
    Publication number: 20100222262
    Abstract: Compositions and methods for reducing cardiovascular risk utilizing substituted 1,3-cyclopentadione compounds are described.
    Type: Application
    Filed: April 2, 2009
    Publication date: September 2, 2010
    Applicant: METAPROTEOMICS, LLC
    Inventors: Veera Konda, Anu Desai, Matthew L. Tripp, Gary K. Darland, Joseph Lamb, Jeffrey S. Bland, Dennis A. Emma
  • Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
    Patent number: 7736677
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: June 15, 2010
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Veera Konda, Amy Hall, Linda M. Pacioretty, Anu Desai
  • SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH
    Publication number: 20100137449
    Abstract: Compounds and methods for multi-targeted protein kinase modulation for angiogenesis, cancer treatment or the inflammatory pathways associated with those conditions are disclosed. The compounds and methods disclosed are based on substituted 1,3-cyclopentadione compounds.
    Type: Application
    Filed: December 10, 2008
    Publication date: June 3, 2010
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Veera Konda, Anu Desai, Gary Darland, Brian J. Carroll, James S. Traub, Linda M. Pacioretty, Dennis Emma
  • Treatment modalities for autoimmune diseases
    Patent number: 7718198
    Abstract: Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: May 18, 2010
    Assignee: Metaproteomics, LLC
    Inventors: Matthew Tripp, Jeffrey S. Bland, Robert Lerman, Amy Hall, Veera Konda, Anu Desai
  • METHODS AND COMPOSITIONS FOR PROMOTING BONE AND JOINT HEALTH
    Publication number: 20100069422
    Abstract: Methods and compositions that can be used to promote bone and joint health through amelioration, stabilization and repair of damage associated with various pathophysiological conditions are disclosed.
    Type: Application
    Filed: November 25, 2009
    Publication date: March 18, 2010
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Anu Desai, Amy J. Hall, Jeffrey S. Bland
  • Methods and Compositions for Heavy Metal Detoxification
    Publication number: 20090155382
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Application
    Filed: February 13, 2008
    Publication date: June 18, 2009
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy Hall, Anu Desai, Jeffrey S. Bland
  • Protein Kinase Modulation by Hops and Acacia Products
    Publication number: 20080248131
    Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis o prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
    Type: Application
    Filed: August 9, 2006
    Publication date: October 9, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Amy J. Hall, Veera Konda, Anu Desai
  • Methods and Compositions for Promoting Bone and Joint Health
    Publication number: 20080242690
    Abstract: Methods and compositions that can be used to promote bone and joint health through amelioration, stabilization and repair of damage associated with various pathophysiological conditions are disclosed.
    Type: Application
    Filed: March 14, 2008
    Publication date: October 2, 2008
    Inventors: Matthew L. Tripp, Veera Konda, Anu Desai, Amy J. Hall, Jeffrey S. Bland
  • Isoalpha acid based protein kinase modulation cancer treatment
    Publication number: 20080051466
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on isoalpha acids, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 28, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
    Publication number: 20080051465
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 28, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
    Publication number: 20080031982
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on tetrahydro-isoalpha acids, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 7, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Hexahydro-isoalpha acid based protein kinase modulation cancer treatment
    Publication number: 20080033057
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on hexahydro-isoalpha acids, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 7, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai